Koh HY - Search Results

1

Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.

Jo MN, Seo HJ, Kim Y, Seo SH, Rhim H, Cho YS, Cha JH, Koh HY, Choo H, Pae AN. Jo MN, et al. Among authors: koh hy. Bioorg Med Chem. 2007 Jan 1;15(1):365-73. doi: 10.1016/j.bmc.2006.09.051. Epub 2006 Oct 10. Bioorg Med Chem. 2007. PMID: 17035033

2

Design and synthesis of a piperazinylalkylisoxazole library for subtype selective dopamine receptor ligands.

Cha MY, Choi BC, Kang KH, Pae AN, Choi KI, Cho YS, Koh HY, Lee HY, Jung D, Kong JY. Cha MY, et al. Among authors: koh hy. Bioorg Med Chem Lett. 2002 May 20;12(10):1327-30. doi: 10.1016/s0960-894x(02)00179-8. Bioorg Med Chem Lett. 2002. PMID: 11992769

3

QSAR studies on piperazinylalkylisoxazole analogues selectively acting on dopamine D3 receptor by HQSAR and CoMFA.

Cha MY, Lee IY, Cha JH, Choi KI, Cho YS, Koh HY, Pae AN. Cha MY, et al. Among authors: koh hy. Bioorg Med Chem. 2003 Apr 3;11(7):1293-8. doi: 10.1016/s0968-0896(02)00617-x. Bioorg Med Chem. 2003. PMID: 12628656

4

Synthesis and in vitro activity of new methylenepiperidinyl and methylenepyrrolidinyl oxazolidinone antibacterial agents.

Kim HY, Lee JS, Cha JH, Pae AN, Cho YS, Chang MH, Koh HY. Kim HY, et al. Among authors: koh hy. Bioorg Med Chem Lett. 2003 Jul 7;13(13):2227-30. doi: 10.1016/s0960-894x(03)00249-x. Bioorg Med Chem Lett. 2003. PMID: 12798339

5

The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA.

Choo HY, Choi S, Jung SH, Koh HY, Pae AN. Choo HY, et al. Among authors: koh hy. Bioorg Med Chem. 2003 Oct 15;11(21):4585-9. doi: 10.1016/s0968-0896(03)00530-3. Bioorg Med Chem. 2003. PMID: 14527555

6

Synthesis and in vitro activity of novel isoxazolyl tetrahydropyridinyl oxazolidinone antibacterial agents.

Lee JS, Cho YS, Chang MH, Koh HY, Chung BY, Pae AN. Lee JS, et al. Among authors: koh hy. Bioorg Med Chem Lett. 2003 Nov 17;13(22):4117-20. doi: 10.1016/j.bmcl.2003.08.021. Bioorg Med Chem Lett. 2003. PMID: 14592519

7

First pharmacophoric hypothesis for T-type calcium channel blockers.

Doddareddy MR, Jung HK, Lee JY, Lee YS, Cho YS, Koh HY, Pae AN. Doddareddy MR, et al. Among authors: koh hy. Bioorg Med Chem. 2004 Apr 1;12(7):1605-11. doi: 10.1016/j.bmc.2004.01.034. Bioorg Med Chem. 2004. PMID: 15028253

8

3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.

Doddareddy MR, Jung HK, Cha JH, Cho YS, Koh HY, Chang MH, Pae AN. Doddareddy MR, et al. Among authors: koh hy. Bioorg Med Chem. 2004 Apr 1;12(7):1613-21. doi: 10.1016/j.bmc.2004.01.028. Bioorg Med Chem. 2004. PMID: 15028254

9

Hologram quantitative structure activity relationship studies on 5-HT6 antagonists.

Doddareddy MR, Lee YJ, Cho YS, Choi KI, Koh HY, Pae AN. Doddareddy MR, et al. Among authors: koh hy. Bioorg Med Chem. 2004 Jul 15;12(14):3815-24. doi: 10.1016/j.bmc.2004.05.005. Bioorg Med Chem. 2004. PMID: 15210148

10

Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.

Jung HK, Doddareddy MR, Cha JH, Rhim H, Cho YS, Koh HY, Jung BY, Pae AN. Jung HK, et al. Among authors: koh hy. Bioorg Med Chem. 2004 Aug 1;12(15):3965-70. doi: 10.1016/j.bmc.2004.06.011. Bioorg Med Chem. 2004. PMID: 15246072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters